Vistapharm patents expiration

1. Thyquidity patents expiration

THYQUIDITY's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9050307 VISTAPHARM Method for the preparation of a levothyroxine solution
Aug, 2031

(7 years from now)

Drugs and Companies using LEVOTHYROXINE SODIUM ingredient

Market Authorisation Date: 30 November, 2020

Treatment: NA


How can I launch a generic of THYQUIDITY before it's drug patent expiration?
More Information on Dosage

THYQUIDITY family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic